SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Intel settles case with Jewish ex-employee who alleged antisemitic retaliation

Bybit breach: How hackers stole $1.5 billion without breaking blockchain security

Adi Dangot Zukovsky joins Ibex Investors as partner following fund’s leadership shift

‘It was through their lies that they became multimillionaires’: Charlie Javice fraud trial opens

Buzz

Most popular

Daily

Weekly

1

Insight Partners hit by cyber attack with possible data leaks

2

Adi Dangot Zukovsky joins Ibex Investors as partner following fund’s leadership shift

3

CyberArk’s surge, Wiz and Cato prepare for IPOs: Israeli cyber firms ready for the next big move

4

Riskified cuts staff as struggles continue

5

Yad2 now valued at $420 million as investors line up for potential sale

ALS

5 stories about ALS

NeuroSense & NeuraLight R&D Teams

NeuroSense Therapeutics and NeuraLight collaborate to detect ALS using AI

The collaboration between the Israeli companies will help the scientific community better understand Amyotrophic lateral sclerosis (ALS) and develop effective drugs to treat it

מוסף שבועי 10.9.20 ד"ר פיטר סקוט־מורגן

Mind over Matter: The man who turned himself into a cyborg to overcome ALS

13.09.20|Yoghev Carmel

After Peter Scott-Morgan was given a year to live, he decided to fight his fate and employed cutting edge technology to stay alive and remain human

תרופה תרופות סל התרופות

ALS Drug Developer NeuroSense Crowdfunds $1.15 Million

05.08.19|Adi Pick

The company’s 1,114 new investors will jointly own a 10% stake, the company said

Kadimastem Gets FDA Orphan Drug Designation for ALS Drug

04.11.18|Lilach Baumer

The biotech company is currently conducting an early clinical trial in Israel and expects results in mid-2019

חיים לייבוביץ' מנכ"ל בריינסטורם

Israeli ALS Treatment Developer Recruits Kite Pharma's CSO as Board Member

05.02.18|Dror Reich

Nasdaq-listed BrainStorm develops stem cell therapies for degenerative neurological diseases